Literature DB >> 12374687

Human papillomavirus type 16 and squamous cell carcinoma of the head and neck.

Elin Ringström1, Edward Peters, Masayuki Hasegawa, Marshall Posner, Mei Liu, Karl T Kelsey.   

Abstract

PURPOSE: Human papillomavirus (HPV) has previously been reported to be associated with squamous cell carcinoma of the head and neck. Our objective was to investigate the presence and type of HPV infection in head and neck tumors and determine whether infection was associated with individual tumor characteristics, patients' pattern of tobacco and alcohol exposure, or with clinical outcome. EXPERIMENTAL
DESIGN: Using a case series design, fresh tumor samples were obtained from a series of 89 head and neck squamous cell carcinoma patients, including 64 men and 25 women. The majority of tumors were located in the oral cavity, followed by the oropharynx. A PCR-based technique with restriction fragment length polymorphism analysis was used to detect and type HPV.
RESULTS: Of the 89 patients, 18 (20%) had detectable HPV 16 in their tumor samples. HPV 16 was detected in 64% of tonsil tumors, 52% oropharyngeal tumors, and 5% oral cavity tumors. The mean age of subjects with HPV 16-positive tumors was younger than the patients with HPV-negative tumors. Also, this group consumed less alcohol on a weekly basis and had a better clinical outcome compared with the HPV-negative group. Smoking, clinical stage, tumor grade, and tumor-node-metastasis status were not associated with HPV 16 presence.
CONCLUSIONS: Our study supports the previous reports that suggest HPV 16 is associated with squamous cell cancers located in the oropharynx and oral cavity. The fact that HPV-positive tumors were observed in younger, lighter alcohol-consuming individuals with a better overall and disease-specific survival suggests a distinct disease process in these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374687

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  78 in total

1.  Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population.

Authors:  M Paz Cañadas; F Xavier Bosch; M Luisa Junquera; Maijo Ejarque; Rebeca Font; Elena Ordoñez; Silvia de Sanjosé
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 2.  The role of HPV in head and neck cancer and review of the HPV vaccine.

Authors:  Gypsyamber D'Souza; Amanda Dempsey
Journal:  Prev Med       Date:  2011-10       Impact factor: 4.018

Review 3.  Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system.

Authors:  Margaret Brandwein-Gensler; Richard V Smith
Journal:  Head Neck Pathol       Date:  2010-02-06

4.  Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer.

Authors:  Xiaoxiang Guan; Erich M Sturgis; Dapeng Lei; Zhensheng Liu; Kristina R Dahlstrom; Qingyi Wei; Guojun Li
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

5.  Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol use.

Authors:  C S Furniss; M D McClean; J F Smith; J Bryan; K M Applebaum; H H Nelson; M R Posner; K T Kelsey
Journal:  Ann Oncol       Date:  2008-12-15       Impact factor: 32.976

6.  Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers.

Authors:  Xingming Chen; Erich M Sturgis; Adel K El-Naggar; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2008-08-13       Impact factor: 4.944

7.  Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma.

Authors:  Katie M Applebaum; Michael D McClean; Heather H Nelson; Carmen J Marsit; Brock C Christensen; Karl T Kelsey
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

8.  Human papillomavirus is not associated with colorectal cancer in a large international study.

Authors:  Michele C Gornick; Xavier Castellsague; Gloria Sanchez; Thomas J Giordano; Michelle Vinco; Joel K Greenson; Gabriel Capella; Leon Raskin; Gad Rennert; Stephen B Gruber; Victor Moreno
Journal:  Cancer Causes Control       Date:  2010-01-20       Impact factor: 2.506

9.  Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.

Authors:  Solomon Jo; Agnes Juhasz; Keqiang Zhang; Christopher Ruel; Sofia Loera; Sharon P Wilczynski; Yun Yen; Xiyong Liu; Joshua Ellenhorn; Dean Lim; Benjamin Paz; George Somlo; Nayana Vora; Stephen Shibata
Journal:  Anticancer Res       Date:  2009-05       Impact factor: 2.480

10.  Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer.

Authors:  Shamir P Chandarana; Julia S Lee; Eric J P Chanowski; Assuntina G Sacco; Carol R Bradford; Gregory T Wolf; Mark E Prince; Jeffrey S Moyer; Avraham Eisbruch; Francis P Worden; Thomas J Giordano; Bhavna Kumar; Katrina G Cordell; Thomas E Carey; Douglas B Chepeha
Journal:  Head Neck       Date:  2012-08-21       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.